Transitioning Together Boston

Status Recruiting

Clinical Trial Summary

A randomized controlled trial will be conducted to determine the effects of an adapted family-centered autism transition intervention called Transitioning Together/Juntos en la Transición on meaningful outcomes for families. The study will occur in a safety net hospital setting. The adapted version of this multi-family group psychoeducation intervention is delivered across one individual family joining session and four 2.5 hour multi-family group sessions. The parent and youth groups are held in separately, at the same time.

Clinical Trial Description

Objective 1: The investigators will test the efficacy of the adapted version of Transitioning Together on youth quality of life and progress toward individual transition goals. 128 English and/or Spanish speaking families of youth ages 14-21 years will be enrolled in the study. The primary enrollment site is Boston Medical Center (BMC), an urban safety net hospital where patients predominantly (>75%) from low-income households are served. The effects of Transitioning Together will be compared to a usual care control condition with a referral to the Transition Specialist within BMC's Developmental and Behavioral Pediatrics clinic. Youth quality of life and progress toward individual transition goals will be compared from baseline and three-to-six months following randomization. The investigators hypothesize that Transitioning Together will have a significant positive effect on youth quality of life and goal attainment across the two time points. Objective 2: Additional standardized assessments will be administered to the 128 parents and the 128 autistic youth, to examine the effects of Transitioning Together compared to the control condition on: the broader family unit's well-being, empowerment, coping skills, social support, transition readiness, and family climate. The investigators will explore whether these factors act to mediate or moderate primary or secondary study outcomes (youth quality of life and progress toward individual transition goals). These putative mediators and moderators will be assessed at the baseline and 3-to 6-months following randomization. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05599711
Study type	Interventional
Source	Boston Medical Center
Contact	Mei L Elansary, MD
Phone	617-414-6373
Email	mei.elansary@bmc.org
Status	Recruiting
Phase	N/A
Start date	February 10, 2023
Completion date	December 2024

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04065867` - Use ICT to Promote Family Well-being in Hong Kong
Completed	`NCT02792309` - Impact Evaluation of MotherWise Program	N/A
Completed	`NCT02902003` - Testing Relationship Skills Education Services With a Robust Economic Security Component	N/A
Completed	`NCT01037946` - Family to Family: Psychoeducation to Improve Children's Outcomes in HIV+ Families	N/A
Completed	`NCT00996541` - Support To Reunite Involve and Value Each Other	N/A
Recruiting	`NCT05977114` - 4Rs for a Better Family	N/A
Completed	`NCT04257331` - Parent Training to Reduce Behavioral Problems in Children With Autism Spectrum Disorder in China	N/A
Completed	`NCT03487796` - MySTYLE: Online Family-based HIV Prevention for Non-heterosexual Black Adolescent Males in the South	N/A
Recruiting	`NCT05172297` - Internet-based Universal Parent Training as a Booster to PATHS®: Parent Web	N/A
Completed	`NCT03127579` - Family Meal Duration and Children's Eating Behavior	N/A
Recruiting	`NCT04362475` - Community Health Through Engagement and Environmental Renewal	N/A
Active, not recruiting	`NCT04370964` - Evolution of Family Alliance in Families With a Designated Adolescent Patient (12-18 Years) During a Family Therapy Process	N/A
Completed	`NCT03828370` - DWI Offenders and Their Families App for Smartphones	N/A
Recruiting	`NCT03960372` - Public Education to Promote Family Communication and Well-being
Not yet recruiting	`NCT06275412` - Family Intervention for Black Teens With Type 1 Diabetes	N/A
Recruiting	`NCT05275413` - mHealth Intervention to Reduce Maternal Postnatal Depression and Promote Family Health	N/A
Recruiting	`NCT06156124` - The Role of Family and Individual Factors in Going Through Adolescence - Perspective of a Healthy Child.
Not yet recruiting	`NCT05477901` - Impacts of Cash Transfers on Child Neurodevelopment (Auxilio Brasil)	N/A
Recruiting	`NCT05356247` - Lausanne Trialogue Paradigm - Brief: A Family Model for Child Mental Health in a Community Setting	N/A
Recruiting	`NCT03872895` - Adjustment of Adopted Adolescents in Their Families

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.